Marie-Louise VachonM.D., M.Sc., FRCP(C)

Pedersen J, Moukandja IP, Ndidi S, Sørensen AL, Koumakpayi IH, Lekana-Douki JB, Vachon ML, Weis N, Kobinger G, Fausther-Bovendo H

An adaptable platform for in-house hepatitis C serology

J Virol Methods, 308 , 2022.

Résumé | Liens:

Marathe G, Moodie EE, Brouillette MJ, Delaunay CL, Cox J, Martel-Laferrière V, Gill J, Cooper C, Pick N, Vachon ML, Walmsley S, Klein MB,

Impact of HCV cure on depressive symptoms in the HIV-HCV co-infected population in Canada

Clin Infect Dis, 2022.

Résumé | Liens:

Onofrio FQ, Cooper C, Borgia SM, Vachon ML, Ramji A, Lilly LB, Wong A, Booth J, Sattar I, Morales H, Lee S, Conway B, Feld JJ

Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry

Clin Infect Dis, 72 (11), 2021.

Résumé | Liens:

Manion M, Lynn N, Pei L, Hammoud DA, Laidlaw E, Roby G, Metzger D, Mejia Y, Lisco A, Zelazny A, Holland S, Vachon ML, Scherer M, Bergin C, Sereti I

To Induce Immune Reconstitution Inflammatory Syndrome or Suppress It: The Spectrum of Mycobacterium genavense in the Antiretroviral Era

Clin Infect Dis, 72 (2), 2021.

Résumé | Liens:

Cooper CL, Read D, Vachon ML, Conway B, Wong A, Ramji A, Borgia S, Tam E, Barrett L, Smyth D, Feld JJ, Lee S,

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

BMC Public Health, 20 (1), 2020.

Résumé | Liens:

Saeed S, Strumpf E, Moodie EEM, Wong L, Cox J, Walmsley S, Tyndall M, Cooper C, Conway B, Hull M, Martel-Laferriere V, Gill J, Wong A, Vachon ML, Klein MB,

Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus

Clin Infect Dis, 71 (2), 2020.

Résumé | Liens:

Murphy DG, Dion R, Simard M, Vachon ML, Martel-Laferrière V, Serhir B, Longtin J

Molecular surveillance of hepatitis C virus genotypes identifies the emergence of a genotype 4d lineage among men in Quebec, 2001-2017

Can Commun Dis Rep, 45 (9), 2019.

Résumé | Liens:

Rossi C, Saeed S, Cox J, Vachon ML, Martel-Laferriere V, Walmsley SL, Cooper C, Gill MJ, Hull M, Moodie EEM, Klein MB,

Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients

AIDS, 32 (6), 2018.

Résumé | Liens:

Feld JJ, Ramji A, Shafran SD, Willems B, Marotta P, Huchet E, Vachon ML, Svarovskaia ES, Huang KC, Hyland RH, Yun C, Massetto B, Brainard DM, McHutchison JG, Tam E, Bailey R, Cooper C, Yoshida EM, Greenbloom S, Elkhashab M, Borgia S, Swain MG

Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study

Clin Infect Dis, 65 (1), 2017.

Résumé | Liens:

Young J, Rossi C, Gill J, Walmsley S, Cooper C, Cox J, Martel-Laferriere V, Conway B, Pick N, Vachon ML, Klein MB,

Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV

Clin Infect Dis, 64 (9), 2017.

Résumé | Liens: